as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹341.0
Change
-4.7 (-1.36%)
Open
₹345.25
Prev. Close
₹345.7
Day High
₹348.0
Day Low
₹339.25
Volume Analysis
Traded
111,248
Delivered
66,801
Delivery %
60.05%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (0)
No signal for this stock
Opportunities (0)
No signal for this stock
Threats (1)
- •FII holding has been falling
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹355.0 | ₹351.5 | ₹346.25 | ₹342.75 | ₹337.5 | ₹334.0 | ₹328.75 |
| Fibonacci | ₹351.5 | ₹348.16 | ₹346.09 | ₹342.75 | ₹339.41 | ₹337.34 | ₹334.0 |
| Camarilla | ₹343.41 | ₹342.6 | ₹341.8 | ₹342.75 | ₹340.2 | ₹339.4 | ₹338.59 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-18.59%
1 Week
-5.91%
1 Month
-0.44%
3 Months
-19.55%
6 Months
+3.87%
1 Year
-24.91%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹243.97
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
11.58%
Net margin 13.38% × asset turnover 0.74x × equity multiplier 1.17x
Company Overview
Sector
Healthcare
Market Cap
₹5,641 Cr
P/E (TTM)
18.3
ROE
11.2%
Book Value
₹153.0
Face Value
₹1.0
Source: Screener.in (Consolidated figures) — data as of 24 Sep 2026. Not investment advice.
TopFund Analysis
Fdc Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 57/100. The strongest factor is Financial Strength (100/100), while Institutional Ownership (15/100) is the weakest area to weigh before deciding. FII holding has been falling.
TopFund Score — Fundamentals Quality
57/100 — AverageData confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company has reduced debt.
- +Company is almost debt free.
- +Company has been maintaining a healthy dividend payout of 19.8%
- −The company has delivered a poor sales growth of 10.3% over past five years.
- −Company has a low return on equity of 12.3% over last 3 years.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Newspaper Publication - Corrigendum to 86th AGM Notice- Cut-off date & Book Closure period FY 2025-26.
AGM notice corrected: e-voting cut-off date September 17, 2026; book closure September 18-23, 2026.
Newspaper Publication of the convening of the 86th Annual General Meeting of the Company.
Submitted Business Responsibility and Sustainability Report for FY 2025-26 under Regulation 34.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 536 | 486 | 458 | 462 | 638 | 514 | 464 | 492 | 648 | 473 | 465 | 585 | 668 |
| Expenses + | 414 | 410 | 374 | 406 | 492 | 444 | 417 | 438 | 508 | 439 | 412 | 478 | 525 |
| Operating Profit | 122 | 76 | 84 | 56 | 147 | 70 | 47 | 54 | 140 | 34 | 52 | 106 | 143 |
| OPM % | 23.0% | 16.0% | 18.0% | 12.0% | 23.0% | 14.0% | 10.0% | 11.0% | 22.0% | 7.0% | 11.0% | 18.0% | 21.0% |
| Other Income + | 29 | 27 | 25 | 20 | 28 | 35 | 19 | 16 | 36 | 21 | 0 | 50 | 48 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| Depreciation | 10 | 10 | 10 | 10 | 11 | 14 | 13 | 16 | 15 | 15 | 15 | 14 | 15 |
| Profit before tax | 141 | 93 | 98 | 65 | 163 | 90 | 51 | 53 | 160 | 38 | 36 | 140 | 175 |
| Tax % | 22.0% | 25.0% | 19.0% | 29.0% | 27.0% | 20.0% | 28.0% | 27.0% | 24.0% | 26.0% | 22.0% | 26.0% | 24.0% |
| Net Profit + | 110 | 70 | 79 | 46 | 119 | 72 | 37 | 39 | 121 | 28 | 28 | 103 | 132 |
| EPS in Rs | 7 | 4 | 5 | 3 | 7 | 4 | 2 | 2 | 7 | 2 | 2 | 6 | 8 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 888 | 994 | 1,013 | 1,074 | 1,089 | 1,341 | 1,331 | 1,525 | 1,784 | 1,943 | 2,108 | 2,171 | 2,190 |
| Expenses + | 690 | 765 | 769 | 841 | 860 | 1,038 | 997 | 1,271 | 1,533 | 1,604 | 1,783 | 1,825 | 1,855 |
| Operating Profit | 199 | 229 | 243 | 233 | 229 | 304 | 334 | 254 | 251 | 339 | 325 | 346 | 335 |
| OPM % | 22.0% | 23.0% | 24.0% | 22.0% | 21.0% | 23.0% | 25.0% | 17.0% | 14.0% | 17.0% | 15.0% | 16.0% | 15.0% |
| Other Income + | 46 | 39 | 44 | 45 | 42 | 57 | 95 | 76 | 50 | 102 | 91 | 93 | 118 |
| Interest | 2 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 4 | 4 | 5 | 5 | 5 |
| Depreciation | 39 | 34 | 35 | 35 | 33 | 37 | 38 | 37 | 39 | 40 | 54 | 59 | 59 |
| Profit before tax | 204 | 232 | 252 | 241 | 237 | 320 | 388 | 289 | 258 | 396 | 357 | 375 | 390 |
| Tax % | 27.0% | 27.0% | 25.0% | 28.0% | 28.0% | 25.0% | 22.0% | 25.0% | 25.0% | 23.0% | 25.0% | 25.0% | — |
| Net Profit + | 148 | 169 | 189 | 174 | 170 | 240 | 301 | 216 | 194 | 305 | 267 | 281 | 293 |
| EPS in Rs | 8 | 9 | 11 | 10 | 10 | 14 | 18 | 13 | 12 | 19 | 16 | 17 | 18 |
| Dividend Payout % | 27.0% | 24.0% | 21.0% | 0.0% | 0.0% | 6.0% | 0.0% | 0.0% | 0.0% | 0.0% | 31.0% | 29.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 919 | 1,065 | 1,252 | 1,259 | 1,428 | 1,530 | 1,717 | 1,940 | 1,965 | 2,081 | 2,265 | 2,469 |
| Borrowings + | 2 | 1 | 1 | 1 | 1 | 15 | 15 | 32 | 28 | 21 | 21 | 15 |
| Other Liabilities + | 210 | 182 | 197 | 228 | 194 | 250 | 208 | 281 | 333 | 350 | 412 | 418 |
| Total Liabilities | 1,148 | 1,266 | 1,468 | 1,505 | 1,640 | 1,813 | 1,956 | 2,270 | 2,343 | 2,468 | 2,714 | 2,919 |
| Fixed Assets + | 393 | 675 | 678 | 674 | 682 | 674 | 689 | 705 | 699 | 680 | 852 | 999 |
| CWIP | 29 | 20 | 6 | 13 | 12 | 24 | 19 | 105 | 198 | 261 | 137 | 96 |
| Investments | 489 | 325 | 491 | 471 | 585 | 665 | 790 | 886 | 806 | 843 | 1,028 | 1,048 |
| Other Assets + | 237 | 246 | 293 | 348 | 360 | 451 | 458 | 575 | 640 | 684 | 698 | 775 |
| Total Assets | 1,148 | 1,266 | 1,468 | 1,505 | 1,640 | 1,813 | 1,956 | 2,270 | 2,343 | 2,468 | 2,714 | 2,919 |
| Equity Capital | 18 | 18 | 18 | 18 | 18 | 17 | 17 | 17 | 17 | 16 | 16 | 16 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 128 | 174 | 154 | 150 | 112 | 250 | 207 | 162 | 155 | 221 | 318 | 200 |
| Cash from Investing Activity + | -89 | -73 | -144 | 21 | -121 | -98 | -77 | -145 | 11 | -17 | -199 | -110 |
| Cash from Financing Activity + | -48 | -97 | 0 | -169 | 0 | -142 | -129 | -10 | -180 | -202 | -92 | -93 |
| Net Cash Flow | -9 | 4 | 11 | 1 | -8 | 10 | 1 | 7 | -14 | 2 | 26 | -3 |
| CFO/OP | 96 | 101 | 92 | 94 | 81 | 110 | 90 | 95 | 93 | 96 | 129 | 83 |
| Free Cash Flow | 83 | -130 | 130 | 114 | 70 | 247 | 148 | 35 | 47 | 151 | 227 | 40 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 19.8% | 20.15% | 20.76% | 21.11% | 21.71% | 21.6% | 21.42% | 20.76% | 21.1% | 21.76% | 21.65% | 22.63% |
| Promoters | 69.66% | 69.66% | 69.66% | 69.66% | 69.66% | 69.66% | 69.66% | 69.66% | 69.66% | 69.66% | 69.65% | 69.65% |
| FII | 2.42% | 2.43% | 2.65% | 2.51% | 2.62% | 2.67% | 2.56% | 2.41% | 2.43% | 2.32% | 2.4% | 1.4% |
| DII | 8.12% | 7.76% | 6.94% | 6.72% | 6.02% | 6.08% | 6.37% | 7.17% | 6.81% | 6.27% | 6.29% | 6.31% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Fdc Limited (this stock) | 5,641 | 18.3 | 2.26 | 11.2% |
| Gujarat Themis Biosyn Ltd | 5,442 | 112.0 | — | — |
| Artemis Med Service Ltd | 5,917 | 51.0 | 6.34 | 12.0% |
| Iol Chem And Pharma Ltd | 5,965 | 33.8 | 3.31 | 8.41% |
| Rpg Life Sciences Ltd | 5,045 | 43.2 | 8.34 | 19.3% |
| Senores Pharmaceuticals L | 6,241 | 49.4 | 6.67 | 13.4% |
| Orchid Pharma Limited | 6,377 | 353.0 | 3.55 | 1.49% |
Which Mutual Funds Hold Fdc Limited?
Frequently Asked Questions about Fdc Limited
Fdc Limited (FDC) closed at ₹341.0 on NSE on 25 September 2026, down 4.7 (1.36%) from the previous close.
Fdc Limited trades on the NSE (National Stock Exchange of India) under the symbol FDC.
Fdc Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 18.3.
Fdc Limited has a dividend yield of 1.44%.
Fdc Limited's 52-week high is ₹476.0 and its 52-week low is ₹313.0.
Fdc Limited has a market capitalisation of ₹5,641 crore.
Fdc Limited has a TopFund Quality Score of 57/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Fdc Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.